Werewolf Therapeutics (HOWL), announced the appointment of Anil Singhal, Ph.D., President and CEO of Trishula Therapeutics, as a member of its board of directors. Concurrent with the appointment of Dr. Singhal, Werewolf announced that Derek DiRocco plans to resign as a director of the Company, effective as of the Company’s 2025 annual meeting of stockholders.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HOWL:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue